ORGANIC COMPOUNDS
    1.
    发明申请
    ORGANIC COMPOUNDS 有权
    有机化合物

    公开(公告)号:US20130005770A1

    公开(公告)日:2013-01-03

    申请号:US13616081

    申请日:2012-09-14

    CPC分类号: C07D401/12

    摘要: The present invention relates to a compound of the formula I wherein R1, R2, R3, R4 and R5 are as defined in the specification, for use in the diagnostic and therapeutic treatment of a warm-blooded animal, especially for the treatment of a disease (=disorder) that depends on activity of renin; the use of a compound of that class for the preparation of a pharmaceutical formulation for the treatment of a disease that depends on activity of renin; the use of a compound of that class in the treatment of a disease that depends on activity of renin; pharmaceutical formulations a compound of that class; a method of treatment comprising administering a compound of that class and a method for its manufacture.

    摘要翻译: 本发明涉及式I化合物,其中R1,R2,R3,R4和R5如说明书中所定义,用于诊断和治疗温血动物,特别是用于治疗疾病 (=无效),依赖于肾素的活性; 使用该类化合物制备用于治疗依赖于肾素活性的疾病的药物制剂; 使用该类化合物治疗依赖于肾素活性的疾病; 药物制剂是该类化合物; 一种治疗方法,包括施用该类化合物及其制备方法。

    Organic compounds
    2.
    发明授权
    Organic compounds 有权
    有机化合物

    公开(公告)号:US08497286B2

    公开(公告)日:2013-07-30

    申请号:US13616081

    申请日:2012-09-14

    IPC分类号: A61K31/444 C07D211/32

    CPC分类号: C07D401/12

    摘要: The present invention relates to a compound of the formula I wherein R1, R2, R3, R4 and R5 are as defined in the specification, for use in the diagnostic and therapeutic treatment of a warm-blooded animal, especially for the treatment of a disease (=disorder) that depends on activity of renin; the use of a compound of that class for the preparation of a pharmaceutical formulation for the treatment of a disease that depends on activity of renin; the use of a compound of that class in the treatment of a disease that depends on activity of renin; pharmaceutical formulations a compound of that class; a method of treatment comprising administering a compound of that class and a method for its manufacture.

    摘要翻译: 本发明涉及式I化合物,其中R1,R2,R3,R4和R5如说明书中所定义,用于诊断和治疗温血动物,特别是用于治疗疾病 (=无效),依赖于肾素的活性; 使用该类化合物制备用于治疗依赖于肾素活性的疾病的药物制剂; 使用该类化合物治疗依赖于肾素活性的疾病; 药物制剂是该类化合物; 一种治疗方法,包括施用该类化合物及其制备方法。

    ORGANIC COMPOUNDS
    4.
    发明申请
    ORGANIC COMPOUNDS 有权
    有机化合物

    公开(公告)号:US20080319018A1

    公开(公告)日:2008-12-25

    申请号:US12146073

    申请日:2008-06-25

    CPC分类号: C07D401/12

    摘要: The present invention relates to a compound of the formula I wherein R1, R2, R3, R4 and R5 are as defined in the specification, for use in the diagnostic and therapeutic treatment of a warm-blooded animal, especially for the treatment of a disease (=disorder) that depends on activity of renin; the use of a compound of that class for the preparation of a pharmaceutical formulation for the treatment of a disease that depends on activity of renin; the use of a compound of that class in the treatment of a disease that depends on activity of renin; pharmaceutical formulations a compound of that class; a method of treatment comprising administering a compound of that class and a method for its manufacture.

    摘要翻译: 本发明涉及式I化合物,其中R1,R2,R3,R4和R5如说明书中所定义,用于诊断和治疗温血动物,特别是用于治疗疾病 (=无效),依赖于肾素的活性; 使用该类化合物制备用于治疗依赖于肾素活性的疾病的药物制剂; 使用该类化合物治疗依赖于肾素活性的疾病; 药物制剂是该类化合物; 一种治疗方法,包括施用该类化合物及其制备方法。

    3, 4, 5 - Substituted Piperidine Compounds
    7.
    发明申请
    3, 4, 5 - Substituted Piperidine Compounds 审中-公开
    3,4,5 - 取代的哌啶化合物

    公开(公告)号:US20100160305A1

    公开(公告)日:2010-06-24

    申请号:US11908182

    申请日:2006-03-07

    摘要: 3,4,5-substituted piperidine compounds, these compounds for use in the diagnostic and therapeutic treatment of a warm-blooded animal, especially for the treatment of a disease (=disorder) that depends on activity of renin; the use of a compound of that class for the preparation of a pharmaceutical formulation for the treatment of a disease that depends on activity of renin; the use of a compound of that class in the treatment of a disease that depends on activity of renin; pharmaceutical formulations comprising a 3,4,5-substituted piperidine compound, and/or a method of treatment comprising administering a 3,4,5-substituted piperidine compound, a method for the manufacture of a 3,4,5-substituted piperidine compound, and novel intermediates and partial steps for its synthesis.The compounds are of the formula I, wherein the substitutents are as defined in the specification.

    摘要翻译: 3,4,5-取代的哌啶化合物,这些化合物用于诊断和治疗温血动物,特别是用于治疗依赖于肾素活性的疾病(=病症); 使用该类化合物制备用于治疗依赖于肾素活性的疾病的药物制剂; 使用该类化合物治疗依赖于肾素活性的疾病; 包含3,4,5-取代的哌啶化合物的药物制剂和/或治疗方法,包括给予3,4,5-取代的哌啶化合物,制备3,4,5-取代哌啶化合物的方法 ,以及其合成的新型中间体和部分步骤。 化合物是式I,其中取代基如说明书中所定义。